In a resounding celebration of leadership, innovation, and impact, the
Hyderabad | January 28, 2026: Granules India Limited today signed
GenWorks Collaborates with Andhra Pradesh Government
To empower women’s wellness The government of Andhra Pradesh has been proactively leading from the front in treating serious problems like Cancer. Under the visionary
Complex Robot-Assisted Surgery for Narrowed Ureter of Transplanted Kidney successfully performed at Fortis Bannerghatta
51-year-old Omani patient who underwent unrelated kidney transplant suffered complications resulting in recurrent urinary tract infection - Fortis Hospital Bannerghatta Road achieved yet another clinical
Spine societies from across the globe discuss Spine Care for G20 countries at 4th SPINE20 Annual Summit
Spine societies from across the world brainstorm recommendations for G20 countries on spine care. Mr. Amitabh Kant, former Niti Aayog CEO, and G20
Mr. Amitabh Kant, Sherpa G20,
Recommendations by Spine20 The media wanted highlights of National Spin Care Program and Spine 20 2023 draft recommendations. Please find below the highlights of the
Government adopting holistic approach to make India global hub of Medical Devices, set to become $50 billion industry soon: Dr. Mansukh Mandaviya
Generic medicine’s share in Pharma to be more than 50%: Dr. Mansukh Mandaviya Indian Medical Devices sector to play an important role in achieving Atmanirbhar Bharat mission:
Mumbai Doctor saved life by using mechanical thrombectomy after 18 hours of Brain Stroke
Mumbai- Death due to brain attack, i.e. stroke or paralysis is increasing worldwide. The first 4 hours are considered as the golden period to
Annual Day and Graduation Day 2023 at Maheshwara Medical College & Hospital on 10th and 11th August
Maheshwara Medical College & Hospital is celebrating its Annual Day on August 10th and Graduation Day on August 11th, 2023 at their campus near
CEPI to support development of selfamplifying mRNA vaccine technology for use against Disease X
CEPI to provide funding of up to US$3.6 million to advance the development of Gennova Biopharmaceutical’s self-amplifying thermostable mRNA vaccine platform to develop vaccine candidates against